
Chemical Structure
Gardiquimod [1020412-43-4]

AG-CR1-3583
Overview
- SupplierAdipoGen Life Sciences
- Product NameGardiquimod
- Delivery Days Customer10
- ADR Class6.1
- CAS Number1020412-43-4
- CertificationResearch Use Only
- Estimated Purity>98%
- Hazard InformationDanger,Excepted quantity
- Molecular FormulaC17H23N5O
- Molecular Weight313.4
- Scientific DescriptionChemical. CAS: 1020412-43-4. Formula: C17H23N5O. MW: 313.4. Synthetic. Immune response modifier. Antiviral and antitumor compound Selective ligand for human or mouse Toll-like receptor 7 (TLR7). Induces the activation of NF-kappaB in HEK 293 cells expressing TLR7 at 0.1microg/ml. 10 times more active than Imiquimod (Prod. No. AG-CR1-3569 http://www.adipogen.com/ag-cr1-3569/imiquimod.html ). At high concentrations (3microg/ml) slightly activates TLR8. Shows adjuvant activity to increase the effectiveness of vaccines. - Immune response modifier. Antiviral and antitumor compound Selective ligand for human or mouse Toll-like receptor 7 (TLR7). Induces the activation of NF-kappaB in HEK 293 cells expressing TLR7 at 0.1microg/ml. 10 times more active than Imiquimod (Prod. No. AG-CR1-3569 http://www.adipogen.com/ag-cr1-3569/imiquimod.html ). At high concentrations (3microg/ml) slightly activates TLR8. Shows adjuvant activity to increase the effectiveness of vaccines.
- SMILESCCNCC1=NC2=C(N1CC(C)(C)O)C1=C(C=CC=C1)N=C2N
- Storage Instruction-20°C,2°C to 8°C
- UN NumberUN 2811
- UNSPSC12352200